Search

Search Constraints

You searched for: Author/Creator Verver, Daniëlle

Search Results

1. False positive FDG uptake in melanoma patients treated with talimogene laherparepvec (T‐VEC). Issue 7 (8th July 2021)

2. Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma. Issue 4 (21st April 2022)

3. Risk stratification of sentinel node–positive melanoma patients defines surgical management and adjuvant therapy treatment considerations. (June 2018)

4. The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node–positive melanoma without the need for completion lymph node dissection. (July 2020)

5. Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas. (2nd November 2019)

6. Using a clinicopathologic and gene expression (CP-GEP) model to identify stage I-II melanoma patients at risk for disease relapse. Issue 2 (February 2023)